Anavex Life Sciences Corp (AVXL)

[nidan7500]

AAIC - for Friday AVXL is planned as a WW Virtual event...

We recognize of course that ANY AAIC exposure is an opportunity to show the AVXL flag and to credit the WW staff-Team's contribution by naming names. All good.

Doc328

Study of the mechanism of action of Blarcamesine (ANAVEX®2-73): Whole blood transcriptomics analysis identifies treatment impact on compensatory pathways by restoring key neurodegenerative pathways functionality, including Alzheimer’s disease pathway
Virtual Platform
Sun, Jul 31
7:00am - 11:55pm (Pacific)


Author Block: Coralie Williams, MSc1; Martin Kindermans, MSC1; Frédéric Parmentier, PhD1; Federico Goodsaid, PhD1; Edward Hammond, MD, PhD, MPH2; Christopher U Missling, PhD2 and Mohammad Afshar, MD, PhD1, (1)Ariana Pharma, Paris, France, (2)Anavex Life Sciences Corp., New York, NY, USA